Kinetics of Physiological and Behavioural Responses in Endotoxemic Pigs with or without Dexamethasone Treatment.
dexamethasone
endotoxemia
lipopolysaccharide
physiological responses
pig
sickness behaviour
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
20 Mar 2019
20 Mar 2019
Historique:
received:
18
02
2019
revised:
17
03
2019
accepted:
19
03
2019
entrez:
23
3
2019
pubmed:
23
3
2019
medline:
13
7
2019
Statut:
epublish
Résumé
Although dexamethasone (DEX) is a widely used immunoregulatory agent, knowledge about its pharmacological properties in farm animals, especially pigs, is insufficient. Previous studies suggest that compared to other species, pigs are less sensitive to the immunosuppression conferred by DEX and more sensitive to the threat of bacterial endotoxins. However, there is a paucity of studies examining DEX immunomodulation in endotoxemia in this species. In this study, a porcine endotoxemia model was established by lipopolysaccharide (LPS) and the effect of DEX-pretreatment on the magnitude and kinetics of neuroendocrine, metabolic, hematologic, inflammatory, and behavioural responses were examined. DEX decreased cortisol, adrenocorticotropic hormone (ACTH), red blood cell, hemoglobin, hematocrit, and lymphocyte whereas glucose concentration was increased under both normal and endotoxemic conditions. By contrast, DEX decreased triglyceride, lactate, and IL-6 concentrations and increased platelet count only under an endotoxemic condition. DEX also reduced the frequency of sickness behaviour following LPS challenge. PCA showed that glucose and triglyceride metabolism together with red blood cell count mainly contributed to the separation of clusters during DEX treatment. Our study demonstrates that DEX protects pigs from inflammation and morbidity in endotoxemia, in spite of their less sensitivity to DEX. Moreover, its considerable role in the regulation of the metabolic and hematologic responses in endotoxemic pigs is revealed for the first time.
Identifiants
pubmed: 30897706
pii: ijms20061393
doi: 10.3390/ijms20061393
pmc: PMC6471452
pii:
doi:
Substances chimiques
Cytokines
0
Lipopolysaccharides
0
Triglycerides
0
Dexamethasone
7S5I7G3JQL
Adrenocorticotropic Hormone
9002-60-2
Glucose
IY9XDZ35W2
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : 391382814
Références
Biol Neonate. 2002;81(3):203-9
pubmed: 11937727
Int Immunopharmacol. 2003 Apr;3(4):571-9
pubmed: 12689661
J Endotoxin Res. 2003;9(1):3-24
pubmed: 12691614
J Lipid Res. 1992 Dec;33(12):1765-76
pubmed: 1479286
Viral Immunol. 2005;18(1):41-78
pubmed: 15802953
Poult Sci. 1992 Apr;71(4):643-9
pubmed: 1594516
Blood. 2005 Oct 1;106(7):2417-23
pubmed: 15961512
FASEB J. 2007 Feb;21(2):402-14
pubmed: 17185747
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
J Endocrinol. 2008 May;197(2):189-204
pubmed: 18434349
Brain Res. 2008 Sep 10;1229:1-17
pubmed: 18644352
Autoimmun Rev. 2011 Apr;10(6):305-10
pubmed: 21224015
Metabolism. 2011 Nov;60(11):1500-10
pubmed: 21864867
Crit Care Med. 2012 Jan;40(1):199-207
pubmed: 21926575
FASEB J. 2012 Apr;26(4):1640-51
pubmed: 22202675
Mol Psychiatry. 2013 Sep;18(9):1006-17
pubmed: 23089634
Innate Immun. 2014 Jan;20(1):30-9
pubmed: 23606516
Vet J. 2013 Oct;198(1):286-8
pubmed: 23876308
Nat Commun. 2013;4:2657
pubmed: 24150174
Can J Physiol Pharmacol. 2013 Dec;91(12):1071-5
pubmed: 24289078
Thromb Haemost. 2014 Oct;112(4):666-77
pubmed: 24966015
Amino Acids. 2015 Jul;47(7):1309-18
pubmed: 25795418
Vet Immunol Immunopathol. 2015 Aug 15;166(3-4):58-69
pubmed: 26099806
Lipids Health Dis. 2015 Jun 30;14:64
pubmed: 26121977
PLoS One. 2015 Jul 31;10(7):e0134653
pubmed: 26230340
BMC Genomics. 2015 Nov 17;16:961
pubmed: 26578410
Animal. 2016 Jul;10(7):1204-12
pubmed: 26863995
Br J Pharmacol. 2017 Jun;174(12):1620-1632
pubmed: 27435156
Open Biol. 2016 Jul;6(7):
pubmed: 27440422
Int J Biochem Cell Biol. 2016 Dec;81(Pt B):307-314
pubmed: 27477311
PLoS One. 2016 Oct 13;11(10):e0164348
pubmed: 27736954
Nat Commun. 2016 Oct 25;7:13280
pubmed: 27779186
BMC Vet Res. 2017 Jan 17;13(1):23
pubmed: 28095847
FASEB J. 2017 Jul;31(7):3054-3065
pubmed: 28373208
Can Vet J. 2017 Apr;58(4):371-376
pubmed: 28373729
Cytokine Growth Factor Rev. 2017 Jun;35:85-96
pubmed: 28479044
Shock. 2018 Jun;49(6):641-648
pubmed: 29028771
Nature. 2017 Nov 2;551(7678):115-118
pubmed: 29045397
Int J Mol Sci. 2017 Oct 20;18(10):null
pubmed: 29053578
Int J Mol Sci. 2017 Oct 18;18(10):null
pubmed: 29057830
Int J Pharm. 2018 Apr 5;540(1-2):57-64
pubmed: 29408684
Circ Res. 2018 Jun 22;123(1):43-56
pubmed: 29794022
Biol Lett. 2018 Jul;14(7):
pubmed: 30021859
Physiol Behav. 2018 Oct 15;195:98-111
pubmed: 30077671
Front Immunol. 2018 Jul 30;9:1736
pubmed: 30105022
Animal. 2019 Jan 10;:1-10
pubmed: 30626452
Vet Res Commun. 1987;11(4):305-23
pubmed: 3499703
Shock. 1995 Aug;4(2):89-95
pubmed: 7496903
Blood Coagul Fibrinolysis. 1994 Apr;5(2):249-55
pubmed: 8054458
J Anim Sci. 1997 Jun;75(6):1514-20
pubmed: 9250511
Circulation. 1998 Nov 24;98(21):2307-13
pubmed: 9826319